Clinical significance of the TK1 specific activity in the early detection of ovarian cancer
Forskningsartikel (Vetenskapligt granskad)
Kiran Kumar Jagarlamudi
Institutionen för anatomi, fysiologi och biokemi
Fakulteten för veterinärmedicin och husdjursvetenskap
E-post: kirankumar.j@slu.se
ORCID: 0000-0003-1567-5863
Publikationer
2023
2022
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
Forskningsartikel (Vetenskapligt granskad)
Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies
Forskningsartikel (Vetenskapligt granskad)
2019
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions
Forskningsartikel (Vetenskapligt granskad)
2018
Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development
Forskningsartikel (Vetenskapligt granskad)
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Översiktsartikel (Vetenskapligt granskad)
2016
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
Forskningsartikel (Vetenskapligt granskad)
2015
Diagnostic implications of the molecular forms and levels of serum thymidine kinase 1 in different canine malignancies
Doktorsavhandling
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management : Dog TK1-ELISA
Forskningsartikel (Vetenskapligt granskad)
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Forskningsartikel (Vetenskapligt granskad)